Regarding "Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft".
T M
TM
Bergamini
D000818:Animals; D018441:Biofilms; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D003131:Combined Modality Therapy; D004285:Dogs; D006801:Humans; D008954:Models, Biological; D011093:Polyethylene Terephthalates; D016459:Prosthesis-Related Infections / Q000382:microbiology / Q000628:therapy*; D011552:Pseudomonas Infections / Q000382:microbiology / Q000628:therapy*; D012086:Reoperation; D012293:Rifampin / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000382:microbiology / Q000628:therapy*; D013212:Staphylococcus epidermidis
D011093:Polyethylene Terephthalates; D012293:Rifampin